Ciclosporin or cyclosporine

This classification denotes a multidrug resistance modulator and immunosuppressant with the molecular formula C62H111N11O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 83HN0GTJ6D, chemically known as cyclosporin a, tolypocladium inflatum but more generally known as ciclosporin, which bears US NIH Compound Identifier 5280754. European Medicines Agency schedules Ciclosporin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06250MIG. The term CICLOSPORIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). World Health Organization schedules ciclosporin in its Anatomical Therapeutic Chemical (ATC) Classification. CICLOSPORIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, CYCLOSPORINE remains US FDA's Preferred Term for this commodity. Cyclosporine bears US NLM identifiers UMLS ID C0010592 and NCI Concept Code C406. SMILES: OC(C1N(C(=O)C(N(C(=O)C(N(C(=O)C(N(C(=O)C(NC(=O)C(NC(=O)C(N(C(=O)C(NC(=O)C(N(C(=O)CN(C(=O)C(NC1=O)CC)C)C)CC(C)C)C(C)C)C)CC(C)C)C)C)C)CC(C)C)C)CC(C)C)C)C(C)C)C)C(C/C=C/C)C.